logo-loader
viewPolarean Imaging PLC

Amphion no longer holds any shares in Polarean Imaging

Amphion had pledged the shares as security against a loan and had no say in the decision to sell the shares

Polarean Imaging PLC - Amphion no longer holds any shares in Polarean Imaging
Amphion remains committed to Polarean's success

The 15.97mln shares in Polarean Imaging PLC (LON:POLX) held by Amphion Innovations PLC’s (LON:AMP) loan facility provider as security against the loan have been sold.

Amphion, which expressed regret at the need for the shares to be sold, does not yet have full details of the application of the sale proceeds; however, total proceeds are estimated at around US$2.5mln.

The last reported loan balance of the credit facility was US$2.3mln.

“The directors consider it to be unfortunate that repayment of the facility required the sale of Amphion's shares in Polarean. Amphion remains committed to Polarean's success and looks forward to supporting the company in the future,” Amphion’s statement said.

Following the sale, Amphion no longer holds any shares in the medical imaging technology company.

Quick facts: Polarean Imaging PLC

Price: 19.98 GBX

AIM:POLX
Market: AIM
Market Cap: £22.86 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polarean Imaging PLC named herein, including the promotion by the Company of Polarean Imaging PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Polarean Imaging eagerly awaiting readouts from its key phase III clinical...

Polarean Imaging PLC's (LON:POLX) Richard Hullihen speaks to Proactive London's Andrew Scott following the news they've now completed patient enrolment for the phase III clinical trials of its MRI lung scan technology. He says the trials are now in the image and statistical analysis stage, a...

1 week, 1 day ago

2 min read